BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/5/2014 11:43:00 AM | Browse: 480 | Download: 506
Publication Name World Journal of Gastroenterology
Manuscript ID 9518
Country of Manuscript Source Italy
Received
2014-02-15 21:55
Peer-Review Started
2014-02-20 16:15
To Make the First Decision
2014-03-13 18:48
Return for Revision
2014-03-23 17:00
Revised
2014-04-30 05:59
Second Decision
2014-07-22 16:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-22 17:09
Articles in Press
2014-07-22 18:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-11-05 15:53
Publish the Manuscript Online
2014-11-20 20:51
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Alcohol and hepatocellular carcinoma: A review and a point of view
Manuscript Source Invited Manuscript
All Author List Gianni Testino, Silvia Leone and Paolo Borro
Funding Agency and Grant Number
Corresponding author Gianni Testino, MD, Centro Alcologico Regionale-Regione Liguria, Alcoholic Unit, Department of General Internal and Specialist Medicine, IRCCS AOU San Martino-National Institute for Cancer Research-IST, Padiglione 10, Piazzale R. Benzi 10, 16132 Genova, Italy. gianni.testino@hsanmartino.it
Keywords Alcohol; Alcoholic liver disease; Hepatocellular carcinoma; Percutaneous ablation
Core Tip It is well recognized that one cause of chronic liver disease and hepatocellular carcinoma (HCC) is alcohol consumption. There is only one way of diagnosing HCC, which is early identification through surveillance, when curative treatments become possible. After stopping alcohol intake the risk of liver cancer decreases by 6% to 7% a year, and an estimated time period of 23 years is also needed. Ablation can be regarded as a first-line choice for patients with very early stage HCC. It is important to underline that the choice of treatment should be weighed carefully in the context of a multidisciplinary cancer team.
Publish Date 2014-11-20 20:51
Citation Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: a review and a point of view. World J Gastroenterol 2014; 20(43): 15943-15954
Url http://www.wjgnet.com/1007-9327/full/v20/i43/15943.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i43.15943
Full Article (PDF) WJG-20-15943.pdf
Full Article (Word) WJG-20-15943.doc
Manuscript File 9518-Review.docx
Answering Reviewers 9518-Answering reviewers.pdf
Copyright License Agreement 9518-Copyright assignment.pdf
Peer-review Report 9518-Peer review(s).pdf
Scientific Misconduct Check 9518-CrossCheck.jpg
Scientific Editor Work List 9518-Scientific editor work list.pdf